277 related articles for article (PubMed ID: 25827090)
1. Evaluation of Cell-Free Urine microRNAs Expression for the Use in Diagnosis of Ovarian and Endometrial Cancers. A Pilot Study.
Záveský L; Jandáková E; Turyna R; Langmeierová L; Weinberger V; Záveská Drábková L; Hůlková M; Hořínek A; Dušková D; Feyereisl J; Minář L; Kohoutová M
Pathol Oncol Res; 2015 Sep; 21(4):1027-35. PubMed ID: 25827090
[TBL] [Abstract][Full Text] [Related]
2. Supernatant versus exosomal urinary microRNAs. Two fractions with different outcomes in gynaecological cancers.
Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L
Neoplasma; 2016; 63(1):121-32. PubMed ID: 26639242
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic potential of differentially regulated microRNAs among endometriosis, endometrioid ovarian cancer, and endometrial cancer.
Kumari P; Sharma I; Saha SC; Srinivasan R; Minhas P
J Cancer Res Ther; 2021; 17(4):1003-1011. PubMed ID: 34528556
[TBL] [Abstract][Full Text] [Related]
4. Cell-Free Urinary MicroRNAs Expression in Small-Scale Experiments.
Zavesky L; Jandakova E; Turyna R; Duskova D; Langmeierova L; Weinberger V; Minar L; Horinek A; Kohoutova M
Methods Mol Biol; 2017; 1580():99-106. PubMed ID: 28439829
[TBL] [Abstract][Full Text] [Related]
5. A Non-invasive Liquid Biopsy Screening of Urine-Derived Exosomes for miRNAs as Biomarkers in Endometrial Cancer Patients.
Srivastava A; Moxley K; Ruskin R; Dhanasekaran DN; Zhao YD; Ramesh R
AAPS J; 2018 Jul; 20(5):82. PubMed ID: 29987691
[TBL] [Abstract][Full Text] [Related]
6. Discovery of potential serum and urine-based microRNA as minimally-invasive biomarkers for breast and gynecological cancer.
Ritter A; Hirschfeld M; Berner K; Jaeger M; Grundner-Culemann F; Schlosser P; Asberger J; Weiss D; Noethling C; Mayer S; Erbes T
Cancer Biomark; 2020; 27(2):225-242. PubMed ID: 32083575
[TBL] [Abstract][Full Text] [Related]
7. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H
J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267
[TBL] [Abstract][Full Text] [Related]
8. A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
Langhe R; Norris L; Saadeh FA; Blackshields G; Varley R; Harrison A; Gleeson N; Spillane C; Martin C; O'Donnell DM; D'Arcy T; O'Leary J; O'Toole S
Cancer Lett; 2015 Jan; 356(2 Pt B):628-36. PubMed ID: 25451316
[TBL] [Abstract][Full Text] [Related]
9. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial, ovarian and cervical cancer.
Mu AK; Lim BK; Aminudin N; Hashim OH; Shuib AS
Arch Physiol Biochem; 2016 Jul; 122(3):111-6. PubMed ID: 26849673
[TBL] [Abstract][Full Text] [Related]
10. Extracellular urinary microRNAs as non-invasive biomarkers of endometrial and ovarian cancer.
Hanžek A; Siatka C; Duc AE
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7981-7993. PubMed ID: 36914786
[TBL] [Abstract][Full Text] [Related]
11. New perspectives in diagnosis of gynaecological cancers: Emerging role of circulating microRNAs as novel biomarkers.
Zavesky L; Jandakova E; Turyna R; Langmeierova L; Weinberger V; Minar L; Kohoutova M
Neoplasma; 2015; 62(4):509-20. PubMed ID: 25997972
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients.
Meng X; Joosse SA; Müller V; Trillsch F; Milde-Langosch K; Mahner S; Geffken M; Pantel K; Schwarzenbach H
Br J Cancer; 2015 Nov; 113(9):1358-66. PubMed ID: 26393886
[TBL] [Abstract][Full Text] [Related]
13. Potential of mid-infrared spectroscopy as a non-invasive diagnostic test in urine for endometrial or ovarian cancer.
Paraskevaidi M; Morais CLM; Lima KMG; Ashton KM; Stringfellow HF; Martin-Hirsch PL; Martin FL
Analyst; 2018 Jun; 143(13):3156-3163. PubMed ID: 29878018
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
Torres A; Torres K; Pesci A; Ceccaroni M; Paszkowski T; Cassandrini P; Zamboni G; Maciejewski R
Int J Cancer; 2013 Apr; 132(7):1633-45. PubMed ID: 22987275
[TBL] [Abstract][Full Text] [Related]
15. Expression of microRNAs in the urine of patients with bladder cancer.
Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of circulating microRNAs as non-invasive biomarkers in the diagnosis of ovarian cancer: a case-control study.
Berner K; Hirschfeld M; Weiß D; Rücker G; Asberger J; Ritter A; Nöthling C; Jäger M; Juhasz-Böss I; Erbes T
Arch Gynecol Obstet; 2022 Jul; 306(1):151-163. PubMed ID: 34889994
[TBL] [Abstract][Full Text] [Related]
17. Detection of microRNA in urine to identify patients with endometrial cancer: a feasibility study.
Donkers H; Hirschfeld M; Weiß D; Erbes T; Jäger M; Pijnenborg J; Bekkers R; Galaal K
Int J Gynecol Cancer; 2021 Jun; 31(6):868-874. PubMed ID: 33911004
[TBL] [Abstract][Full Text] [Related]
18. microRNA and Ovarian Cancer.
Langhe R
Adv Exp Med Biol; 2015; 889():119-51. PubMed ID: 26659000
[TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of serum exosomal miR-375 and miR-1307 enhance the diagnostic power of CA125 for ovarian cancer.
Su YY; Sun L; Guo ZR; Li JC; Bai TT; Cai XX; Li WH; Zhu YF
J Ovarian Res; 2019 Jan; 12(1):6. PubMed ID: 30670062
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]